Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

L. Vasanthamohan, Thomas DeLoughery

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)JC52
JournalAnnals of internal medicine
Issue number10
StatePublished - Nov 20 2018

ASJC Scopus subject areas

  • Internal Medicine

Cite this